The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 31, 2018

Filed:

Apr. 05, 2017
Applicants:

University of Kansas, Lawrence, KS (US);

Saint Louis Univeristy, St. Louis, MO (US);

Inventors:

David J. Davido, Lawrence, KS (US);

Lynda Anne Morrison, Webster Groves, MO (US);

Assignees:

University of Kansas, Lawrence, KS (US);

Saint Louis University, St. Louis, MO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/763 (2015.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 35/76 (2015.01); A61K 39/00 (2006.01); C07K 14/005 (2006.01); A61K 39/245 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01);
Abstract

A mutant HSV-1 (referred to herein as KOS-NA) was generated. KOS-NA contains novel mutations in the UL39 gene, which encodes for a protein that is a large subunit of ribonucleotide reductase (i.e., ICP6). These UL39 mutations were found to alter two amino acids in ICP6 (R950H and L393P) and are responsible for attenuation of KOS-NA in vivo, and resulted in diminished ICP6 protein levels. These novel UL39 mutations regulate the expression and/or stability of ICP6 and severely impact HSV-1 pathogenesis. Mutant HSV viruses containing these mutations appear to protect against HSV infection and can serve as therapeutic vaccines to help combat preexisting HSV infection in infected individuals.


Find Patent Forward Citations

Loading…